Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-02-05

FDA Approved: NADOLOL — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nadolol submitted by Zydus Pharmaceuticals USA Inc., resulting in updated labeling and/or indications for Nadolol. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nadolol (Nadolol)

Snippet

SUPPL AP for NADOLOL (NADOLOL)